Home › Multiple Sclerosis › Arizona
Multiple Sclerosis clinical trials in Arizona
6 studies for Multiple Sclerosis are looking for participants at sites in Arizona.
Cities in Arizona
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Arizona, Tucson
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 10, 2026 · NCT07002034A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Gilbert
- TG Therapeutics Investigational Trial Site, Phoenix
- TG Therapeutics Investigational Trial Site, Scottsdale
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT06433752A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Clinical Endpoints, LLC, Scottsdale
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Oct 30, 2026 · NCT07609719A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Perseverance Research Center,LLC, Scottsdale
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Oct 27, 2026 · NCT06782490Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Center for Neurology and Spine - Phoenix - East Bell Road- Site Number : 8400195, Phoenix
- Perseverance Research Center- Site Number : 8400138, Scottsdale
- Center for Neurosciences - Tucson- Site Number : 8400194, Tucson
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Oct 13, 2026 · NCT07325292A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Xenoscience Inc, Phoenix
- Ctr for Neurology and Spine, Phoenix
- AZ Integrated Neuro and Spine, Phoenix
- and 1 more
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Oct 13, 2026 · NCT07225504From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.